
zzso zzso zzso zzso by weight is recommended as zzso therapy for the initial treatment of zzso zzso zzso and as zzso for long-term treatment of zzso zzso In zzso zzso such as those with zzso impairment or the elderly, zzso dosing may be zzso and capping the dose in obese patients may lead to inadequate zzso 

We determined the frequency of zzso zzso characteristics zzso zzso advanced age, zzso and cancer among zzso patients in clinical practice, and assessed whether these characteristics appeared to influence the type and dose of zzso zzso 

During zzso among consecutive patients with zzso at two large Canadian hospitals, the proportions with the above characteristics were calculated and treatments prescribed were zzso 

Of zzso zzso patients, zzso were aged zzso 75 zzso zzso zzso impairment zzso clearance zzso zzso zzso zzso was present in zzso of patients, and severe zzso impairment zzso zzso 30 zzso zzso in zzso of zzso zzso was prescribed to zzso of patients with severe zzso impairment and to zzso of patients with moderate zzso zzso Body weight was zzso 100 zzso in zzso of zzso zzso of zzso by zzso zzso was documented in zzso of such patients compared with zzso of patients zzso 100 zzso zzso zzso zzso Among zzso of patients with active cancer, only one-third were prescribed zzso zzso 

In clinical practice, zzso zzso advanced age, obesity and cancer are frequently present in patients with zzso A considerable proportion of these patients may not receive the optimal type or dose of medication to treat zzso 

